Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	348
Malignant neoplasm of bronchus and lung (C34.3)	162
Malignant neoplasm of rectum (C20)	131
Malignant neoplasm of bronchus and lung (C34.0)	109
Non-follicular lymphoma (C83.3)	106
Malignant neoplasm of bronchus and lung (C34.8)	90
Malignant neoplasm of colon - Malignant neoplasm of sigmoid colon (C18.7)	66
Malignant neoplasm of colon - Malignant neoplasm of cecum (C18.0)	63
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	54
Malignant neoplasm of ovary (C56)	50

Top 10 treatments

Treatment	Number
(9-984.7)	621
Others therapeutic procedures to influence the immune system (8-547.1)	565
(9-984.b)	539
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	402
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	279
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	258
(9-984.8)	207
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	169
(9-984.6)	146
Administration of medicines in accordance with List 2 of the procedures list (6-002.72)	120

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Koronare Herzkrankheit (KHK)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ05

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
113	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
85	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
69	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB02	Health and paediatric nurse (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB10	Midwife (m/f)
HB17	Auxiliary nurse (m/f)